Author:
Peng Ying,Peng Chongsheng,Wu Yang,Sun Chongzhi,Li Xiaobo
Abstract
Abstract
Background
The Prinsepia utilis Royle leaves (P. utilis) is a folk herb used for benign prostatic hyperplasia (BPH) control by ethnic minorities for centuries in China with rich in resources. Our previous studies have confirmed the anti-BPH effect of its water extract (QCJ) and the active fraction (Fr. B) separated from the QCJ by animal test. The Fr. B from P. utilis should be a potential candidate for BPH control.
Methods
In this study, the chemical ingredients of Fr. B were identified by UPLC-QTOF-MS, and quantified by HPLC. Murine animal models were divided into 8 groups, Sham rats, BPH rats, BPH rats administered with finasteride (1 mg/kg), BPH rats administered with Pule’an (460 mg/kg), BPH rats administered with low, high dosage of QCJ (860 mg/kg, 2580 mg/kg respectively), BPH rats administered with low, high dosage of Fr. B (160 mg/kg, 480 mg/kg respectively). The expression of vascular endothelial growth factor (VEGF) in the prostate tissue of rats was tested, and serum levels of dihydrotestosterone (DHT), testosterone (T), estradiol (E2), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and total superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT), malondialdehyde (MDA) in prostate homogenate were measured. One-way ANOVA followed by LSD was used for statistical analysis.
Results
The BPH rats treated by Fr. B exhibited significant reductions of VEGF and MDA levels, as well as significant increases of SOD, GSH-Px and CAT in the prostate tissue after 28 day administration (P < 0.05). Moreover, Fr. B significantly reduced DHT, DHT/E2 ratio, TNF-α, while increased T levels in serum of BPH rats (P < 0.05). UPLC-QTOF-MS analysis revealed 10 flavonoids as the key constituents of this fraction, which accounted for 54.96% of all substance of Fr. B. The relative contents of compound 1, 2 are 11.1%, 13% in Fr. B respectively.
Conclusions
These results indicated that the Fr. B obtained from P. utilis alleviated the symptoms of BPH rats through multiple mechanisms including reduction of DHT/E2 ratio, inhibition of growth factor, anti-inflammation and anti-oxidation, in which flavonoids might be the key constituents. It supported the hypothesis that the Fr. B should be further explored as a candidate for BPH patients.
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine
Reference48 articles.
1. Lan M. Materia medicalo of Yunnan. Kunming: People’s Publishing House of Yunnan; 1975.
2. Gupta R, Goyal R, Bhattacharya S, Dhar KL. Antioxidative in vitro and antiosteoporotic activities of Prinsepia utilis Royle in female rats. Eur J Integr Med. 2015;7(2):157–63. https://doi.org/10.1016/j.eujim.2014.10.002.
3. Yang Y, Liu G, Zhang XY, Hu TT, Wang ZG, Li X, et al. Effect of Prinsepia utilis tea on blood lipids in hyperlipidemic mice. Sci Tech Food Industry. 2015;36(13):361–3.
4. Bin G. Studies on the chemical constituents of Prinsepia utilis Royle and anti-tumor activity. Shanghai: Shanghai Jiao Tong University; 2013.
5. Wang YJ, Zhang Y, Du J, Yang LJ, Zhang Q, Sun QQ, et al. Study on the anti-inflammatory active constituents of Prinsepia utilis. West China J Pharm Sci. 2006;21(2):152–4.